RUNX1 mutations can be divided into germline mutations, responsible for familial platelet disorders and predisposition to AML, and somatic mutations, which occur in both lymphoid and myeloid cancers, including AML [74]. Here, RUNX1 is linked to acute myeloid leukemia.